Guanylyl cyclase C (GCC), the receptor for diarrheagenic bacterial heat-stable enterotoxins (STs), inhibits colorectal cancer cell proliferation by co-opting Ca 21 as the intracellular messenger. Similarly, extracellular Ca 21 (Ca 21 o ) opposes proliferation and induces terminal differentiation in intestinal epithelial cells. In that context, human colon cancer cells develop a phenotype characterized by insensitivity to cytostasis imposed by Ca 21 o . Here, preconditioning with ST, mediated by GCC signaling through cyclic nucleotide-gated channels, restored Ca 21 o -dependent cytostasis, reflecting posttranscriptional regulation of calcium-sensing receptors (CaRs). ST-induced GCC signaling deployed CaRs to the surface of human colon cancer cells, whereas elimination of GCC signaling in mice nearly abolished CaR expression in enterocytes. Moreover, ST-induced Ca 21 o -dependent cytostasis was abrogated by CaR-specific antisense oligonucleotides. Importantly, following ST preconditioning, newly expressed CaRs at the cell surface represented tumor cell receptor targets for antiproliferative signaling by CaR agonists. Since expression of the endogenous paracrine hormones for GCC is uniformly lost early in carcinogenesis, these observations offer a mechanistic explanation for the Ca 21 o -resistant phenotype of colon cancer cells. Restoration of antitumorigenic CaR signaling by GCC ligand replacement therapy represents a previously unrecognized paradigm for the prevention and treatment of human colorectal cancer employing dietary Ca 21 supplementation.
Introduction
Colorectal cancer is most prevalent in the developed world, representing the second leading cause of cancer-related mortality (1, 2) . Although the epidemiology of this disease is poorly understood, there is an unexplained inverse relationship between the worldwide incidence of colorectal cancer and enterotoxigenic Escherichia coli infections (3, 4) . Enterotoxigenic E.coli produces heat-stable enterotoxins (STs), exogenous ligands for the intestine-specific receptor guanylyl cyclase C (GCC) (5) and a principle cause of secretory diarrhea in endemic populations and animal herds (6) (7) (8) . Regions of the world with the highest incidence of enterotoxigenic E.coli-associated diarrhea exhibit the lowest incidence of colon cancer (4) . In that context, activation of GCC inhibits human colon carcinoma cell proliferation (4, 9, 10) and adenoma formation in mice (3) .
Reduced expression of the endogenous paracrine hormones for GCC, guanylin and uroguanylin, represents an early mutational event in colorectal carcinogenesis (11) (12) (13) . GCC signaling through its second messenger cGMP promotes fluid and electrolyte secretion (5) , opposes cell cycle progression and proliferation (4, 9) and regulates migration, differentiation and apoptosis along the crypt-villus axis (14, 15) . Importantly, targeted GCC deletion (GCC À/À ) in mice increased intestinal tumorigenesis induced by the carcinogen azoxymethane or adenomatous polyposis coli (APC) mutations by corrupting homeostatic crypt proliferation and genomic integrity (16) . These observations suggest a model in which colorectal cancer is a disease of hormone insufficiency where dysregulation of GCC signaling, following loss of guanylin and uroguanylin, promotes tumorigenesis by disrupting mucosal homeostasis (16) . However, beyond production of cGMP, molecular mechanisms by which GCC regulates processes underlying carcinogenesis remain undefined.
Like GCC, extracellular Ca 2þ (Ca 2þ o ) opposes proliferation and promotes differentiation of intestinal mucosa cells (17) (18) (19) (20) . Moreover, Ca 2þ supplementation abrogates intestinal hyperproliferation and tumor formation induced by a western-style diet in APC Min/þ mice (21) . In part, these antitumorigenic effects may reflect GCCinduced activation of cyclic nucleotide-gated (CNG) channels, inducing cytostasis through Ca 2þ o influx (4) . Notably, Ca 2þ o in the colonic lumen may increase to !20 mM that activates calcium-sensing receptors (CaRs) (19, 22) , G protein-coupled receptors (23) expressed in apical membranes of colonocytes (24) , an event resulting in reduced proliferation and tumorigenesis through inhibition of b-catenin/Tcf-4 signaling, and increased cell maturation through p21 and p27 activities (25, 26) . Conversely, Ca 2þ o supports colorectal cancer cell proliferation by capacitative entry through store-operated Ca 2þ channels (27, 28) , which opposes antiproliferative GCC signaling through CNG and Ca 2þ o entry (28) . Thus, opposing mechanisms regulating proliferative balance by Ca 2þ o comprise functional units reciprocally orchestrated in colon cancer cells (28) .
Here, the functional relationship between GCC and Ca 2þ o was explored in human colon carcinoma cells preconditioned with ST, in the context of a dynamic range of Ca 2þ o , and in GCC À/À mice. These studies revealed a previously unappreciated role for GCC in regulating CaR signaling, offering a novel paradigm for the prevention and treatment of human colorectal cancer employing hormone replacement therapy with GCC ligands in combination with oral Ca 2þ supplementation.
Materials and methods
Tumor cell proliferation Proliferation of cancer cells was quantified in 96 wells per plate by [methyl-3 H]thymidine (0.2 lCi/well) incorporation into DNA (9) . Cells were pulse labeled (3 h) with 3 H-thymidine at the end of 24 h periods of proliferation induced by 10 mM L-glutamine. Following 3 H-thymidine labeling, media was aspirated, cells were incubated for 15 min with ice-cold 10% trichloroacetic acid and rinsed sequentially with 10% trichloroacetic acid and 100% methanol. The acid-insoluble material containing 3 H-labeled DNA was solubilized in 100 ll of 0.2 N NaOH, 80 ll aliquots were dissolved in 1 ml ScintiVerse and radioactivity quantified in a Packard b-scintillation spectrometer. All experiments were conducted on exponentially growing tumor cells.
Tumor cell toxicity
Cytotoxicity, including occurrence of apoptosis or necrosis, was assessed by flow cytometry (9) . Cancer cells ($10 6 cells per well in six-well plates) were treated (24 h) with the indicated reagents. Then, cells were placed in suspension by trypsinization, pelleted by centrifugation, washed with phosphate-buffered saline and fixed in ice-cold 75% ethanol (30 min). After another wash with phosphate-buffered saline, cells were resuspended in the staining solution (50 lg/ml propidium iodide, 100 lg/ml RNase A, 1 mM ethylenediaminetetraacetic acid and 0.1% Triton X-100) and analyzed on a Coulter EPICS XL-MCL flow cytometer. Distribution in different phases of the cell cycle was analyzed using WinMDI software (version 2. Eagle's minimal essential medium supplemented with 2 mM L-glutamine. Reactions were terminated by adding ice-cold 100% ethanol, each well was washed twice with ice-cold 100% ethanol and supernates separated from pellets by centrifugation (12 000g, 15 min at 4°C). Supernates containing cGMP were evaporated in a Savant SVC-100H concentrator (Thermo Electron Corporation, Waltham, MA) and reconstituted with 50 mM sodium acetate (pH 4.0), and cGMP was quantified in each sample in triplicate by radioimmunoassay (4) .
Immunoblot analysis
Proteins from total cell lysates, cytosol or membrane extracts (28) prepared in sodium dodecyl sulfate sample buffer were separated by electrophoresis on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred on nitrocellulose membranes and then probed with rabbit polyclonal antibodies directed against CaR (dilution 1:1000) or human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:1000) or with goat anti-villin antibody [Villin(C-19); 1:1000] in Tris-buffered saline-Tween (5% milk) overnight at 4°C. Then, membranes were probed with horseradish peroxidase-conjugated secondary antibody (dilution 1:5000) for 1 h at room temperature, and specific bands were visualized employing West Pico Chemiluminescent Substrate and subjected to densitometry. Immunoblots, performed under reducing conditions, exhibited only one specific band of $125 kDa corresponding to the monomer form of CaR.
Immunostaining analyses
For immunohistochemistry, tumor cells were washed two times with cold phosphate-buffered saline and immediately fixed (30 min in 4% paraformaldehyde) at room temperature followed by quenching with 3% H 2 O 2 . CaR or CD104 at the cell surface was visualized employing (overnight at 4°C) rabbit anti-CaR (1:100) or mouse monoclonal anti-human CD104 (1:100), respectively, and the Histostain-plus kit. For immunofluorescence, GCC À/À mice, generated by neomycin-resistant gene insertion on an I-129 background (29) and backcrossed with a C57BL/6 strain for seven or more generations, were employed. All animals were treated in compliance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and under a protocol approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University. GCC þ/þ and GCC À/À littermates (males 2 months old; N, three per genotype) were killed, the intestine collected, divided into anatomically comparable segments and processed for paraffin-based archiving. Paraffin-embedded tissue sections (5 lm) were rehydrated, heated (two times for 5 min in citrate buffer, pH 6) for antigen retrieval, incubated overnight (4°C) with rabbit anti-CaR (1:100) or goat anti-villin (1:50) followed by incubation for 30 min (room temperature) with Alexa fluor 555 anti-rabbit IgG (for CaR) or Alexa fluor 488 anti-goat IgG (for villin). Digital images were acquired by computers attached to a light microscope or a confocal laser scanning microscope (LSM510, Carl Zeiss, Jena, Germany).
Cell transductions
A 5# 327 bp CaR fragment containing 8 bp of upstream DNA was cloned into MSCV-puro retroviral vectors in both sense and antisense orientations (30) , confirmed by DNA sequencing. Antisense, sense and empty vectors were transfected along with the packaging vector pCL Ampho into HEK 293 cells employing Fugene. Viral supernatants harvested at 48 and 72 h after transfection were used to transduce T84 cells (for 72 h). Then, tumor cells stably transduced with CaR antisense, CaR sense or empty vector were selected employing 5 lg/ml puromycin in Dulbecco's modified Eagle's medium/F12.
Statistical analysis
Data are expressed as the mean ± SEM of a representative of at least three experiments performed in triplicate. Data were analyzed employing the unpaired two-tailed Student's t-test, and significance was assumed for P , 0.05.
Results

Colorectal cancer cells are insensitive to Ca 2þ
o -dependent cytostasis Whereas intestinal epithelial cells along the crypt-villus axis transition from proliferation to differentiation at lumenal Ca 2þ o $2-3 mM (22), neoplastic transformation progressively desensitizes these cells to the cytostatic effects of Ca 2þ o (20) , with ultimate loss of Ca 2þ o -induced cell cycle arrest (31) . Accordingly, Ca 2þ o induced cytostasis ( Figure 1A ), but not cytotoxicity ( Figure 1B) , in moderately and well-differentiated colon cancer cells. However, Ca 2þ o failed to induce cell cycle arrest and a substantial proliferating cell population ($20-30%) persisted at 50 mM Ca 2þ o ( Figure 1A ), consistent with a phenotype of insensitivity to proliferative restriction by Ca 2þ o in human colon cancer cells.
ST potentiates Ca 2þ o -dependent cytostasis by inducing GCC signaling through CNG channels Acute (3 h) ST exposure, which restricts cell cycle progression of colon cancer cells by activating GCC signaling (4,9), induced cytostasis that was additive with Ca 2þ o ( Figure 1C1 ). Indeed, cytostasis induced by acute ST exposure was not altered by Ca 2þ o over a range of 1-50 mM ( Figure 1C2 ), suggesting that the antiproliferative effects of ST and Ca 2þ o are mediated by distinct, non-interfering mechanisms. In contrast, ST preconditioning (24 h), which induces desensitization to GCC-dependent cytostasis in colon cancer cells (10) , potentiated the inhibition of proliferation by Ca 2þ o ( Figure 1C1 ). Thus, ST synergistically increased the potency (IC 50 o to inhibit colon cancer cell proliferation (P , 0.001; Figure 1C1 ). Importantly, while failing to inhibit cell proliferation, reflecting desensitization to cGMP signaling (10) (see conditions at 1 mM Ca 2þ o in Figure 1C1 ), ST preconditioning revealed a novel antiproliferative mechanism that required !3 mM Ca 2þ o ( Figure 1C2 ). Potentiation of Ca 2þ o -induced cytostasis by ST preconditioning was mediated by GCC since ST, but not an inactive analog, inhibited (IC 50 , 62.22 ± 3.21 nM; Figure 2A ) proliferation of human colon carcinoma cells expressing GCC, but not of cells lacking GCC (32) ( Figure 2B) . Similarly, the effects of ST preconditioning were greater in T84 cells, which exhibits the highest GCC expression (32), compared with Caco-2 cells ( Figure 2B ). Further, two membranepermeant cGMP analogs mimicked ( Figure 2B ), whereas an inhibitor of cyclic nucleotide-hydrolyzing phosphodiesterases enhanced ( Figure 2C ), the effects of ST preconditioning on tumor cell proliferation. Conversely, two inhibitors of CNG channels and an intracellular Ca 2þ chelator, but not inhibitors of cGMP-or cAMP-dependent protein kinase, blocked ST-mediated potentiation of Ca 2þ o -dependent cytostasis ( Figure 2C) . Notably, ST did not induce cytotoxicity in colon cancer cells exposed to high Ca 2þ o ( Figure 2D ). Rather, ST delayed the progression of these tumor cells through the cell cycle ( Figure 2D) , consistent with the notion that GCC agonists are cytostatic agents for colon cancer (4,9,10). Together, these observations suggest that in colon cancer cells induction of Ca 2þ o -dependent cytostasis by ST preconditioning is mediated by cGMP-dependent activation of CNG channels and Ca 2þ o entry, the same effector mechanism mediating GCC-induced cell cycle delay (4) . o did not enhance cytostasis induced by GCC signaling (þST for 3 h in Figure 1C2 ) and did not prevent GCCmediated desensitization in cGMP signaling (10) ( Figure 3A) . Rather, ST preconditioning enhanced Ca 2þ o -dependent cytostasis by coupling increased Ca 2þ o with intracellular signaling mechanisms induced by cGMP signaling (Figure 2A-C) . Ca 2þ o induces cytostasis in colonocytes, in part, by activating CaR signaling (22) , a mechanism typically lost during neoplastic transformation (26, 33) . ST preconditioning (!3 h) augmented the complement of total cellular (supplementary Figure 1A is available at Carcinogenesis Online) and membranebound CaRs ( Figure 3B ) without significantly altering cytosolic CaRs ( Figure 3B ) or CaR messenger RNA levels (data not shown). Further, examination of specific cell fractions (supplementary Figure 1B Figure 5C ). Thus, ST preconditioning restores the sensitivity of human colon cancer cells to Ca 2þ o -dependent antiproliferation through CaRs, suggesting GCC-induced CaRs as previously unrecognized therapeutic targets for cytostatic strategies in patients with colorectal cancer.
Discussion
Enterotoxins STs (18 amino acid long) and endogenous paracrine hormones guanylin and uroguanylin (15/16 amino acid long) are structurally homologous peptides (35, 36) , which specifically bind to and activate GCC at enterocyte brush-border membranes inducing cGMP-dependent protein kinase-dependent ion channel currents (36) . In this way, endogenous hormones regulate body fluid homeostasis, whereas STs, principle diarrheagenic agents maximally activating that pathway, permit enterotoxigenic bacteria to propagate in the environment (7, (36) (37) (38) . Of significance, GCC À/À mice exhibit increased proliferation, migration and apoptosis and decreased Enterotoxins restore CaR-mediated cytostasis differentiation along the crypt-villus axis (14) and are more susceptible to intestinal tumorigenesis induced by azoxymethane or APC mutations (16) . Moreover, expression of guanylin and uroguanylin is uniformly lost early in intestinal carcinogenesis (11) (12) (13) , loss of guanylin expression resulted in crypt hyperproliferation (15) and administration of GCC ligands inhibits intestinal tumor formation in APC Min/þ mice (3) and cell cycle progression of colon cancer cells (9) . Thus beyond fluid homeostasis, GCC controls proliferation and tumorigenesis in intestine.
Mechanisms mediating antiproliferation by GCC appear diverse. GCC signaling through unidentified effectors engages colonic cell quality control mechanisms assuring genomic integrity and tumor suppression (16) . Also, GCC-and cGMP-dependent Ca 2þ influx through CNGs induces colon cancer cell cytostasis by reducing Figure 1C2 ; the controls were low (0.5 mM; A) or high (5 mM; B) Ca , 100 lM and spermine, 100 lM. CaR agonists are used at concentrations that maximally induce CaR signaling (34, 40) . Figure 1 legend for keys) . Also, epithelial cells in villus tips from the jejunum of GCC þ/þ and GCC À/À mice were stained with 4#,6-diamidino-2-phenylindole (DAPI) (blue, nuclei) and specific antibodies against villin (green, enterocyte brush-border membranes) and CaR (red) and subjected to confocal microscopy (magnification Â63).
Enterotoxins restore CaR-mediated cytostasis nuclear rates of DNA synthesis (4, 9) . Here, a previously unappreciated mechanism contributing to tumor suppression by GCC is described ( Figure 5D ). ST preconditioning induces cGMP-mediated CNG signaling and synthesis and cell surface delivery of CaRs. Increased CaRs at the plasma membrane, in turn, provide new tumor-specific targets for antiproliferative signaling by CaR agonists, including Ca 2þ o , Mg 2þ , Gd 3þ and spermine. Although mediated by the same proximal effector, Ca 2þ o influx through CNG, inhibition of DNA synthesis (4) and activation of CaR signaling ( Figure 5D ) represent two distinct, non-overlapping GCC-dependent antiproliferative mechanisms, distinguished by acute (minutes) (9) and chronic (!3 h Figure 3B ) kinetics, respectively. They may represent sequential temporal arms of an integrated antiproliferative strategy in which acute cytostasis, silenced by phosphodiesterase-dependent desensitization of cGMP signaling (10) , is propagated by CaR-dependent signaling to ensure enduring colon tumor cytostasis imposed by GCC. Interestingly, CaR signaling also promotes phosphodiesterase-dependent hydrolysis of cGMP (39) , a mechanism that may contribute to desensitize cGMP-mediated inhibition of DNA synthesis and represents a negative feedback loop for cGMP-induced CaR.
First discovered in parathyroid cells where it senses blood Ca 2þ levels and regulates parathyroid hormone release (40) , CaRs are expressed in many cell types, including osteoclasts, neurons and hematopoietic cells (23, 41, 42) . In colonocytes, CaRs sense 1-10 mM Ca 2þ o in fecal water by interacting with the N-terminal extracellular domain, inducing intracellular signaling through heterotrimeric G proteins (23, 43) . One emerging function of CaRs in colonocytes is the regulation of proliferation and differentiation and its putative role as a tumor suppressor (22, 24, 44) . Although the CaR gene is not lost or mutated in colon cancer (33) , CaR expression is inexplicably reduced during disease progression (25, 26, 33) . The present finding that GCC regulates the posttranscriptional expression of CaRs in normal and malignant intestinal cells offers a mechanistic explanation for that observation since GCC signaling is silenced early during colorectal tumorigenesis following loss of ligand expression (11) (12) (13) . Accordingly, elimination of GCC signaling in mice abolished the expression of CaRs in enterocytes (Figure 4) . Moreover, CaRs are primarily expressed in the apex and central regions of human crypts (26) where expression of endogenous GCC ligands and cGMP levels are greatest (45, 46) , suggesting that CaR signaling may be conditionally regulated along the crypt-villus axis by GCC-and cGMP-dependent mechanisms. In this model, the common abilities of CaRs and GCC to promote the transition from proliferation to differentiation and inhibit intestinal carcinogenesis may represent convergent, rather than parallel, signaling pathways. Finally, although they remain to be fully characterized, GCC effects on CaRs, including induction of translation, posttranslational processing or trafficking to cell membranes, represent a previously unrecognized mechanism of transcriptionally independent regulation of CaR surface expression and signaling (47) .
Beyond CaR, Ca 2þ o opposes tumorigenesis by forming benign insoluble complexes with toxic ionized fatty acids and bile acids (48) and promoting cis-dimerization of E-cadherin molecules underlying cell-cell adhesion (49) and growth suppression (50) . This latter mechanism, which occurs at Ca 2þ o . 0.5 mM (49) and induces the function of p27 (50) , may explain, in part, the cytostatic effects of high Ca 2þ o in colon cancer cells not exposed to ST observed here. Indeed, these cells were not affected by CaR antisense delivery ( Figure 5A ) or application of CaR agonists ( Figure 5C ), indicating that in the absence of GCC activation CaRs are functionally silent in colon cancer cells. Loss of GCC (11) (12) (13) and CaR (25, 26, 33) signaling, in turn, may underlie the resistant phenotype of colon cancer cells to Ca 2þ oinduced cytostasis (20, 31) . These observations are significant since levels of 3-10 mM Ca 2þ o , required for significant CaR activation (34) , are typically achieved in the fecal colonic water as a result of dietary Ca 2þ intake, absorption and secretion (19, 22) . Moreover, allosteric CaR activators present in the intestinal lumen such as L-amino acids (23) may further increase the CaR sensitivity for Ca 2þ o . Importantly, CaRs sense other polyvalent cations (i.e. Gd 3þ , Mg 2þ , Ni 2þ and polylysine), including polyamines (spermine, spermidine and putrescine) endogenously produced by colonic bacteria (23) , suggesting that GCC-induced CaRs may subserve diverse tumor suppressor pathways in intestine.
Strategies for cancer control include chemoprevention and chemotherapy. In contrast to its endogenous ligands, GCC is universally overexpressed in colorectal tumors (51, 52) , and oral administration of GCC ligands is a novel targeted approach to prevent tumor initiation and arrest disease progression in patients (3, 4, 9) . Limitations to these therapies include adverse effects associated with the use of diarrheagenic bacterial enterotoxins (7, 37, 38) . Conversely, dietary Ca 2þ supplementation has been proposed as a chemoprevention strategy against colon cancer (53) . However, caution has been suggested based on the reduced efficacy of Ca 2þ o to inhibit intestinal cell proliferation following neoplastic transformation probably reflecting reduced CaR expression (33) o therapy, in turn, may prevent adverse effects of GCC-targeted strategies because activation of CaR opposes secretory diarrhea by bacterial enterotoxins (39) . Taken together, these data suggest that combinatorial therapies including dietary Ca 2þ o supplementation and GCC ligand replacement represent a previously unrecognized paradigm for the prevention and treatment of human colorectal cancer.
